Leukemia & Lymphoma, Volume 10, Issue sup1 (1993)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 10, Issue sup1 (1993)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Volume 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs Download issue

Original Article

Article
Is the Working Formulation Adequate for the Classification of the Low Grade Lymphomas?
William C. Pugh
Pages: 1-8
Published online: 01 Jul 2009
First Page PreviewforIs the Working Formulation Adequate for the Classification of the Low Grade Lymphomas? | References | PDF (1.1 MB)
  • 7 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Can we Identify Patients with Low Grade Lymphoma for Frontline ABMT?
Jorge E. Romaguera
Pages: 9-15
Published online: 01 Jul 2009
AbstractforCan we Identify Patients with Low Grade Lymphoma for Frontline ABMT? | References | PDF (439.4 KB)
  • 6 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
The Role of Interferon in the Therapy of Low Grade Lymphoma
Peter McLaughlin
Pages: 17-20
Published online: 01 Jul 2009
First Page PreviewforThe Role of Interferon in the Therapy of Low Grade Lymphoma | References | PDF (346 KB)
  • 8 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Results of Treatment of Small Non-Cleaved Cell Lymphoma in Patients Without Positive HIV Serology
Fredrick B. Hagemeister
Pages: 21-27
Published online: 01 Jul 2009
AbstractforResults of Treatment of Small Non-Cleaved Cell Lymphoma in Patients Without Positive HIV Serology | References | PDF (505.8 KB)
  • 6 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Combination Chemotherapy in the Treatment of Follicular Low-Grade Lymphoma
Vicki A. Morrison & Bruce A. Peterson
Pages: 29-33
Published online: 01 Jul 2009
AbstractforCombination Chemotherapy in the Treatment of Follicular Low-Grade Lymphoma | References | PDF (474 KB)
  • 20 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Treatment of Low Grade Non-Hodgkin's Lymphomas With Fludarabine
J. S. Whelan, R. Ganjoo, P. W. M. Johnson, A. Z. S. Rohatiner & T. A. Lister
Pages: 35-37
Published online: 01 Jul 2009
First Page PreviewforTreatment of Low Grade Non-Hodgkin's Lymphomas With Fludarabine | References | PDF (230.5 KB)
  • 8 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Anthracycline Containing Regimens in Intermediate Grade Lymphoma
Pier Luigi Zinzani, Sante Tura, Aurelio Cajozzo, Giuseppe Leone, Giuseppe Papa, Patrizia Gentilini, Gabriella Rossi, Enrico Aitini & Franco Mandelli
Pages: 39-41
Published online: 01 Jul 2009
AbstractforAnthracycline Containing Regimens in Intermediate Grade Lymphoma | References | PDF (210.7 KB)
  • 12 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
2-Chlorodeoxyadenosine: A New Nucleoside Agent Effective in the Treatment of Lymphoid Malignancies
Alan Saven & Lawrence D. Piro
Pages: 43-49
Published online: 01 Jul 2009
First Page Previewfor2-Chlorodeoxyadenosine: A New Nucleoside Agent Effective in the Treatment of Lymphoid Malignancies | References | PDF (563.8 KB)
  • 11 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Human B Cell Lymphomas: In Vitro and In Vivo Studies on Growth Factors and Cell Growth
Richard J. Ford, Archie Tamayo, Dai Jun Li & Fernando Cabanillas
Pages: 51-56
Published online: 01 Jul 2009
AbstractforHuman B Cell Lymphomas: In Vitro and In Vivo Studies on Growth Factors and Cell Growth | References | PDF (571.2 KB)
  • 17 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Prognostic Factors in Large-Cell Lymphomas
Bertrand Coiffier & Eric Lepage
Pages: 57-60
Published online: 01 Jul 2009
AbstractforPrognostic Factors in Large-Cell Lymphomas | References | PDF (320.3 KB)
  • 22 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
What is the Role of Third Generation Regimens for Initial Therapy of Non-Hodgkin's Lymphomas?
Julie M. Vose & James O. Armitage
Pages: 61-64
Published online: 01 Jul 2009
AbstractforWhat is the Role of Third Generation Regimens for Initial Therapy of Non-Hodgkin's Lymphomas? | References | PDF (354.1 KB)
  • 6 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Chronic Administration of Etoposide in the Treatment of Non-Hodgkin's Lymphoma
John D. Hainsworth
Pages: 65-72
Published online: 01 Jul 2009
AbstractforChronic Administration of Etoposide in the Treatment of Non-Hodgkin's Lymphoma | References | PDF (686.9 KB)
  • 34 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
Phase II Study of Intravenous Idarubicin in Unfavorable Non-Hodgkin's Lymphoma
Delvyn C. Case, Mirjam C. Gerber, Richard A. Gams, Jeffrey Crawford, May L. Votaw, Celestia S. Higano, Brian T. Pruitt & James Gould
Pages: 73-79
Published online: 01 Jul 2009
AbstractforPhase II Study of Intravenous Idarubicin in Unfavorable Non-Hodgkin's Lymphoma | References | PDF (468.8 KB)
  • 7 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Ki-1-Anaplastic Large Cell Lymphoma: Is it a Discrete Entity?
Harald Stein
Pages: 81-84
Published online: 01 Jul 2009
First Page PreviewforKi-1-Anaplastic Large Cell Lymphoma: Is it a Discrete Entity? | References | PDF (289.2 KB)
  • 11 Views
  • 29 CrossRef citations
  • 0Altmetric
Article
Is There a Role for MACOP-B in the Treatment of Diffuse Large Cell Lymphoma?
Susan E. O'reilly & Joseph M. Connors
Pages: 85-89
Published online: 01 Jul 2009
AbstractforIs There a Role for MACOP-B in the Treatment of Diffuse Large Cell Lymphoma? | References | PDF (295.2 KB)
  • 7 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Are Alkylating Agents a Necessary Component in the Therapy of Hodgkin's Disease
Fredrick B. Hagemeister
Pages: 91-97
Published online: 01 Jul 2009
AbstractforAre Alkylating Agents a Necessary Component in the Therapy of Hodgkin's Disease | References | PDF (517.2 KB)
  • 12 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
What is the Origin of the Malignant Cell in Hodgkin's Disease?
H. Stein & M. Hummel
Pages: 99-102
Published online: 01 Jul 2009
First Page PreviewforWhat is the Origin of the Malignant Cell in Hodgkin's Disease? | References | PDF (290.3 KB)
  • 11 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Bone Marrow Transplantation for Hodgkin's Disease-Recent Advances and Current Issues
Richard Champlin
Pages: 103-108
Published online: 01 Jul 2009
First Page PreviewforBone Marrow Transplantation for Hodgkin's Disease-Recent Advances and Current Issues | References | PDF (548 KB)
  • 8 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Biochemical Modulation of Arabinosylcytosine for Therapy of Leukemias
Varsha Gandhi, Elihu Estey, Michael J. Keating & William Plunkett
Pages: 109-114
Published online: 01 Jul 2009
AbstractforBiochemical Modulation of Arabinosylcytosine for Therapy of Leukemias | References | PDF (508 KB)
  • 56 Views
  • 41 CrossRef citations
  • 0Altmetric
Article
Treatment of Relapsed or Refractory AML with Intermediate-dose Arabinosylcytosine (Ara-C): Confirmation of the Importance of Ara-C Triphosphate Formation in Mediating Response to Ara-C
Elihu H. Estey, William Plunkett, Hagop Kantarjian, Mary Beth Rios & Michael J. Keating
Pages: 115-121
Published online: 01 Jul 2009
First Page PreviewforTreatment of Relapsed or Refractory AML with Intermediate-dose Arabinosylcytosine (Ara-C): Confirmation of the Importance of Ara-C Triphosphate Formation in Mediating Response to Ara-C | References | PDF (539.5 KB)
  • 23 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Effect of Hemopoietic Growth Factors G-CSF and pIXY 321 on the Activity of High Dose ARA-C in Human Myeloid Leukemia Cells
Kapil Bhalla, Elena Tourkina, Yue Huang, Caroline Tang, Mary Ella Mahoney & Ana Maria Ibrado
Pages: 123-131
Published online: 01 Jul 2009
AbstractforEffect of Hemopoietic Growth Factors G-CSF and pIXY 321 on the Activity of High Dose ARA-C in Human Myeloid Leukemia Cells | References | PDF (826.2 KB)
  • 8 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
High-Dose Versus Intermediate Dose Cytosine Arabinoside Combined with Mitoxantrone for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia: Results of an Age Adjusted Randomized Comparison
W. Hiddemann, C. Aul, G. Maschmeyer, R. Schönrock-nabuls, W. D. Ludwig, A. Bartholomäus, P. Bettelheim, K. Becker, L. Balleisen, B. Lathan, H. Köppler, T. Grüneisen, R. Donhuijsenant, A. Reichle, A. Heinecke, C. Sauerland & Th. Büchner
Pages: 133-137
Published online: 01 Jul 2009
AbstractforHigh-Dose Versus Intermediate Dose Cytosine Arabinoside Combined with Mitoxantrone for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia: Results of an Age Adjusted Randomized Comparison | References | PDF (432.5 KB)
  • 54 Views
  • 21 CrossRef citations
  • 0Altmetric
Article
Nucleoside Analogs in Treatment of Chronic Lymphocytic Leukemia
M. J. Keating, S. O'brien, H. Kantarjian, L. B. Robertson, C. Koller, M. Beran & E. Estey
Pages: 139-145
Published online: 01 Jul 2009
AbstractforNucleoside Analogs in Treatment of Chronic Lymphocytic Leukemia | References | PDF (498.8 KB)
  • 19 Views
  • 19 CrossRef citations
  • 0Altmetric
Article
Asparaginase Revisited
Robert L. Capizzi
Pages: 147-150
Published online: 01 Jul 2009
First Page PreviewforAsparaginase Revisited | References | PDF (309 KB)
  • 113 Views
  • 32 CrossRef citations
  • 0Altmetric
Article
Can the Polymerase Chain Reaction Be Used to Direct Therapy?
P. W. M. Johnson & T. A. Lister
Pages: 151-152
Published online: 01 Jul 2009
CitationforCan the Polymerase Chain Reaction Be Used to Direct Therapy? | References | PDF (186.5 KB)
  • 5 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
L-Asparaginase and PEG Asparaginase— Past, Present, and Future
Michael J. Keating, Romayne Holmes, Susan Lerner & Dah Hsi Ho
Pages: 153-157
Published online: 01 Jul 2009
AbstractforL-Asparaginase and PEG Asparaginase— Past, Present, and Future | References | PDF (484.4 KB)
  • 377 Views
  • 144 CrossRef citations
  • 0Altmetric

Miscellaneous Article

Introduction
Michael J. Keating
Page: vii
Published online: 01 Jul 2009
CitationforIntroduction | PDF (52.4 KB)
  • 5 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

High red cell mass and high plasma volume are independently associated with thrombotic risk in polycythemia vera
Ivan Krecak et al.
Letter to the Editor | Published online: 20 Jun 2024
Experience of using venetoclax in relapsed T- cell lymphoma
Jasmine Zain et al.
Letter to the Editor | Published online: 17 Jun 2024
Therapy-related myeloid neoplasms with single-hit TP53 mutations share the clinical, molecular, and survival characteristics of their multi-hit counterparts
Taylor Zak et al.
Article | Published online: 17 Jun 2024
Polycythemia vera: past, present and future
Ami B. Patel et al.
Review Article | Published online: 13 Jun 2024
View all latest articles